NASDAQ:BSGMBioSig Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioSig Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $10.91 -0.10 (-0.91 %) (As of 05/25/2020 04:00 PM ET) Add Compare Share Today's Range$10.65Now: $10.91▼$11.2350-Day Range$4.59MA: $8.11▼$11.4552-Week Range$2.36Now: $10.91▼$12.43Volume419,000 shsAverage Volume1.01 million shsMarket Capitalization$284.86 millionP/E RatioN/ADividend YieldN/ABeta1.42 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.00, BioSig Technologies has a potential downside of 17.5% from its current price of $10.91.Amount of Analyst CoverageBioSig Technologies has only been the subject of 1 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesBioSig Technologies has received 92 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBioSig Technologies has received 79 “underperform” votes. (Add your “underperform” vote.)Community SentimentBioSig Technologies has received 53.80% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BioSig Technologies and other stocks. Vote “Outperform” if you believe BSGM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BSGM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $31,231.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 19.04% of the stock of BioSig Technologies is held by insiders.Percentage Held by InstitutionsOnly 14.98% of the stock of BioSig Technologies is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for BioSig Technologies are expected to grow in the coming year, from ($0.90) to ($0.50) per share.Price to Book Value per Share RatioBioSig Technologies has a P/B Ratio of 20.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.57 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BSGM Previous Symbol CUSIPN/A CIKN/A Webwww.biosig.com Phone203-409-5444Debt Debt-to-Equity Ratio0.01 Current Ratio10.45 Quick Ratio9.95Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.53 per share Price / Book20.58Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-34,060,000.00 Net MarginsN/A Return on Equity-320.08% Return on Assets-273.73%Miscellaneous Employees20 Outstanding Shares26,110,000Market Cap$284.86 million Next Earnings Date7/29/2020 (Estimated) OptionableNot Optionable NASDAQ:BSGM Rates by TradingView Receive BSGM News and Ratings via Email Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions How has BioSig Technologies' stock been impacted by COVID-19 (Coronavirus)? BioSig Technologies' stock was trading at $3.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BSGM shares have increased by 247.5% and is now trading at $10.91. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of BioSig Technologies? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BioSig Technologies. When is BioSig Technologies' next earnings date? BioSig Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for BioSig Technologies. How were BioSig Technologies' earnings last quarter? BioSig Technologies Inc (NASDAQ:BSGM) announced its quarterly earnings data on Monday, May, 11th. The company reported ($0.46) earnings per share for the quarter, missing analysts' consensus estimates of ($0.24) by $0.22. View BioSig Technologies' earnings history. What price target have analysts set for BSGM? 1 brokerages have issued 12 month target prices for BioSig Technologies' stock. Their forecasts range from $9.00 to $9.00. On average, they expect BioSig Technologies' stock price to reach $9.00 in the next twelve months. This suggests that the stock has a possible downside of 17.5%. View analysts' price targets for BioSig Technologies. Has BioSig Technologies been receiving favorable news coverage? News coverage about BSGM stock has trended negative on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. BioSig Technologies earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutBioSig Technologies. Are investors shorting BioSig Technologies? BioSig Technologies saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 2,460,000 shares, a decrease of 8.9% from the April 30th total of 2,700,000 shares. Based on an average daily volume of 763,800 shares, the short-interest ratio is presently 3.2 days. Currently, 12.7% of the company's shares are sold short. View BioSig Technologies' Current Options Chain. Who are some of BioSig Technologies' key competitors? Some companies that are related to BioSig Technologies include InMode (INMD), Natus Medical (NTUS), Zynex (ZYXI), TransMedics Group (TMDX), BioLife Solutions (BLFS), AxoGen (AXGN), Stereotaxis (STXS), Semler Scientific (SMLR), Viewray (VRAY), Cutera (CUTR), Soleno Therapeutics (SLNO), Fonar (FONR), Edap Tms (EDAP), Fc Global Realty (FCRE) and electroCore (ECOR). View all competitors. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Roku (ROKU), Amarin (AMRN), Novavax (NVAX), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Advanced Micro Devices (AMD) and NVIDIA (NVDA). Who are BioSig Technologies' key executives? BioSig Technologies' management team includes the following people: Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 51)Mr. Steven Chaussy, Chief Financial Officer (Age 65)Ms. Lora Mikolaitis, VP of Admin. (Age 46)Mrs. Tiffini Wittwer, Chief Regulatory & Compliance OfficerMr. John Kowalski, VP of Sales What is BioSig Technologies' stock symbol? BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM." Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.43%), State Street Corp (1.07%), Zeke Capital Advisors LLC (0.87%), Geode Capital Management LLC (0.86%), Cambridge Investment Research Advisors Inc. (0.41%) and Wells Fargo & Company MN (0.14%). Company insiders that own BioSig Technologies stock include Kenneth L Londoner, Martha Pease, Samuel E Navarro and Steve Chaussy. View institutional ownership trends for BioSig Technologies. Which major investors are selling BioSig Technologies stock? BSGM stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, UBS Group AG, and IHT Wealth Management LLC. View insider buying and selling activity for BioSig Technologies. Which major investors are buying BioSig Technologies stock? BSGM stock was purchased by a variety of institutional investors in the last quarter, including Zeke Capital Advisors LLC, Parametric Portfolio Associates LLC, Geode Capital Management LLC, BlackRock Inc., Cambridge Investment Research Advisors Inc., Wells Fargo & Company MN, Advisor Group Holdings Inc., and State Street Corp. Company insiders that have bought BioSig Technologies stock in the last two years include Kenneth L Londoner, Martha Pease, Samuel E Navarro, and Steve Chaussy. View insider buying and selling activity for BioSig Technologies. How do I buy shares of BioSig Technologies? Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BioSig Technologies' stock price today? One share of BSGM stock can currently be purchased for approximately $10.91. How big of a company is BioSig Technologies? BioSig Technologies has a market capitalization of $284.86 million. BioSig Technologies employs 20 workers across the globe. What is BioSig Technologies' official website? The official website for BioSig Technologies is www.biosig.com. How can I contact BioSig Technologies? BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company can be reached via phone at 203-409-5444 or via email at [email protected] This page was last updated on 5/26/2020 by MarketBeat.com Staff
